Avenue Therapeutics Inc (ATXI)
0.1289
-0.01
(-4.23%)
USD |
NASDAQ |
Apr 19, 16:00
0.1289
0.00 (0.00%)
After-Hours: 20:00
Avenue Therapeutics Cash from Operations (TTM): -9.451M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -9.451M |
September 30, 2023 | -11.30M |
June 30, 2023 | -10.96M |
March 31, 2023 | -7.239M |
December 31, 2022 | -7.596M |
September 30, 2022 | -4.63M |
June 30, 2022 | -4.612M |
March 31, 2022 | -4.373M |
December 31, 2021 | -3.75M |
September 30, 2021 | -3.74M |
June 30, 2021 | -4.136M |
March 31, 2021 | -4.749M |
December 31, 2020 | -4.613M |
September 30, 2020 | -8.416M |
June 30, 2020 | -9.198M |
Date | Value |
---|---|
March 31, 2020 | -21.86M |
December 31, 2019 | -26.26M |
September 30, 2019 | -22.50M |
June 30, 2019 | -24.92M |
March 31, 2019 | -16.96M |
December 31, 2018 | -18.22M |
September 30, 2018 | -21.25M |
June 30, 2018 | -18.99M |
March 31, 2018 | -13.59M |
December 31, 2017 | -6.802M |
September 30, 2017 | -2.607M |
June 30, 2017 | -1.171M |
March 31, 2017 | -0.789M |
December 31, 2016 | -1.632M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-26.26M
Minimum
Dec 2019
-3.74M
Maximum
Sep 2021
-10.23M
Average
-7.596M
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
Fortress Biotech Inc | -128.22M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |